(Q44583897)

4 December 2017

title

Synthetic peptides in the form of dendrimers become resistant to protease activity (English)

1 reference

4 December 2017

Luisa Bracci

1

1 reference

4 December 2017

Chiara Falciani

2

1 reference

4 December 2017

Barbara Lelli

3

1 reference

4 December 2017

Luisa Lozzi

4

1 reference

4 December 2017

Ylenia Runci

5

1 reference

4 December 2017

Alessandro Pini

6

1 reference

4 December 2017

Maria Graziella De Montis

7

1 reference

4 December 2017

Alessandro Tagliamonte

8

1 reference

4 December 2017

Paolo Neri

9

1 reference

4 December 2017

language of work or name

English

0 references

publication date

12 September 2003

1 reference

Journal of Biological Chemistry

4 December 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

4 December 2017

volume

278

1 reference

4 December 2017

issue

47

1 reference

4 December 2017

page(s)

46590-46595

1 reference

Designing peptide receptor agonists and antagonists

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308615200

Converting a peptide into a drug: strategies to improve stability and bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308615200

New reagents, reactions, and peptidomimetics for drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308615200

Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308615200

Peptide dendrimers: applications and synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308615200

Rational design and molecular diversity for the construction of anti-alpha-bungarotoxin antidotes with high affinity and in vivo efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308615200

In vitro and in vivo evaluation of new radiolabeled neurotensin(8-13) analogues with high affinity for NT1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308615200

Improved tumor selectivity of radiolabeled peptides by receptor and antigen dual targeting in the neurotensin receptor model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308615200

Synthesis and biological studies of novel neurotensin(8-13) mimetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308615200

Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308615200

Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308615200

Soluble metalloendopeptidases and neuroendocrine signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308615200

Stabilization of neurotensin analogues: effect on peptide catabolism, biodistribution and tumor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308615200

Antimicrobial dendrimeric peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308615200

Designing a polyvalent inhibitor of anthrax toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308615200

A branched peptide mimotope of the nicotinic receptor binding site is a potent synthetic antidote against the snake neurotoxin alpha-bungarotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M308615200

21 January 2018

Identifiers

DOI

10.1074/JBC.M308615200

1 reference

4 December 2017

1 reference